The government’s recently published ‘Fit for the Future’ 10-Year Health Plan outlines a significant change in direction for the NHS in England. Among its core pillars is a shift from analogue to digital processes. While the concept of NHS digital transformation is not new, this plan introduces a specific architecture of named policies and platforms intended to reshape how patients interact with the service and how professionals deliver care.
For professionals and organisations across the NHS and life sciences, it’s time to move beyond the headlines and dig down into the mechanics of this shift. This analysis, the first in a three-part series, breaks down the key digital initiatives and assesses their practical implications for strategy, skills, and market access.
The foundation of the digital strategy is the creation of a UK Single Patient Record (SPR). The plan describes this as a "patient passport" that consolidates an individual's health data, from medical history to genomics and data from wearables, into a single, secure account. The goal is to provide clinicians with a unified view of the patient, improving care coordination and safety.
The 10-Year Plan designates the NHS App as the central interface for patient care, with a target for it to be a "full front door to the entire NHS" by 2028. This involves a significant expansion of its capabilities through a new suite of branded tools:
One of the most notable policy shifts is the introduction of the "HealthStore". This will function as a curated, internal marketplace where the NHS will procure and provide patients with access to NICE-approved digital tools and applications.
This development directly addresses a long-standing challenge for industry. By creating a formal, national procurement channel, the plan aims to simplify the complex process of getting digital therapeutics (DTx) and health technologies adopted at scale. For companies in this space, understanding the criteria for entry into the HealthStore will be important for future market access strategies.
The plan’s vision for Artificial Intelligence extends beyond diagnostics to focus heavily on workforce productivity. A key proposal is the scaled deployment of ambient voice technology, also known as "AI scribes", to automate clinical notetaking and alleviate the administrative burden on staff. Citing studies showing this can free up significant clinical time, the policy is positioned as a direct response to clinician burnout.
Beyond productivity, the plan outlines how AI-enabled tools will be used to transform entire clinical pathways, using the current evolution of dermatology as a template. It highlights the success of teledermatology hubs where AI supports the triage of skin lesions, allowing benign cases to be discharged without a hospital appointment and fast-tracking specialist care for those who need it. The plan explicitly states an ambition to expand this model to other specialities, prioritising ophthalmology, cardiology, respiratory medicine, and mental health in the next few years. For companies operating in these areas, particularly respiratory, this signals a clear opportunity to partner with the NHS in developing and implementing new technology-led care models.
While the UK-wide transition away from analogue telephony makes digital systems an inevitable upgrade for all sectors, the plan notes that this infrastructure change will be leveraged to support goals such as improved patient triage and answering calls more quickly.
This digital architecture cannot be implemented without a workforce equipped with the right skills. The plan implicitly creates a demand for new competencies across both the NHS and the life sciences industry.
Navigating this transition will require strong leadership and a focus on change management within all organisations. The success of the plan rests not on the technology itself, but on the ability of people to adapt to and harness it effectively.
The 10-Year Plan's digital proposals are specific and structural. They outline a future where data is unified, patient interaction is channelled through a single app, and new procurement pathways exist for digital health. While the execution of such a large-scale transformation will undoubtedly face budgetary and logistical challenges, the policy direction is clear. For organisations and professionals in healthcare, preparing for this new operating model must begin now.
This analysis is the first in a CHASE series breaking down the core shifts in the NHS 10-Year Plan. In our next article, we will examine the plan’s second major pillar: the proposed shift from a treatment-focused service to one based on prevention and genomics.
Explore our latest thinking, event updates and industry insights to stay informed.
CHASE’s 2024 gender pay gap report highlights progress and ongoing commitment to closing pay gaps and promoting equality in pharma, medtech and biotech sectors.
Sustainability is vital for life sciences and NHS suppliers. CHASE is committed to reducing our environmental impact and supporting partners' Net Zero goals.
CHASE welcomes Dan as Senior Recruitment Consultant in MedTech, bringing 18+ years' UK pharma experience to boost talent and support division growth in 2024.
.svg)
